SJ Medical
As a leading Drug-Eluting Stents (DES) manufacturer, we recognize that the cardiovascular interventional market is undergoing a seismic shift. Globally, the demand for DES is projected to grow significantly as coronary artery disease remains a primary health challenge. The industry has moved from bare-metal stents (BMS) to the first generation of DES, and now into the era of Polymer-Free and Bioresorbable coating technologies.
In developed markets like Europe and North America, the focus is on clinical outcomes such as reduced late-lumen loss and faster re-endothelialization. Meanwhile, in emerging markets, there is a massive procurement demand for high-quality, cost-effective alternatives to premium Western brands. This is where Chinese manufacturing excellence, combined with stringent international quality standards, provides a strategic advantage.
Our DES systems utilize laser-cut cobalt-chromium platforms and proprietary drug-coating techniques to ensure uniform drug release and structural integrity.
The global DES market is expanding at a CAGR of 5.6%, driven by aging populations and technological advancements in minimally invasive surgery.
With distribution in over 30 countries, we ensure that our interventional devices reach hospitals and cath labs with maximum efficiency.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency. Our DES Factory utilizes state-of-the-art balloon forming equipment and laser welding technologies.
In Southeast Asia and the Middle East, high incidences of diabetic-related coronary complications require stents with superior deliverability in calcified lesions. Our systems are optimized for crossability in complex anatomies.
Reducing the risk of late stent thrombosis is critical. Our R&D focuses on polymer-free coatings which eliminate the chronic inflammatory response associated with permanent polymer carriers.
As a China-based manufacturer, we offer flexible OEM solutions for global brands looking to localize their supply chains while maintaining European quality standards.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
The company’s products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
Partnered with clinics in Finland, Italy, Spain, France, and the Netherlands.
Strong presence in India, Indonesia, and Southeast Asian medical hubs.
Established supply routes in Turkey, Egypt, and the Middle Eastern coronary care centers.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
SJ Medical is committed to providing comprehensive and professional services throughout the entire customer journey. From pre-sales consultation and technical support to efficient order processing and responsive after-sales service, the company ensures that every customer receives timely assistance and reliable solutions.